• Explore /
  • Poster
  • / Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).

Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).

Abstract Poster

Authors

null

Sergio Bracarda

Azienda Ospedaliera Santa Maria, Terni, Italy

Sergio Bracarda , Lorenzo Antonuzzo , Marco Maruzzo , Daniele Santini , Rosa Tambaro , Sebastiano Buti , Francesco Carrozza , Fabio Calabrò , Giuseppe Di Lorenzo , Giuseppe Fornarini , Roberto Iacovelli , Daniela Cullurà , Carlo Messina , Linda Cerbone , Gennaro Fazzi , Filippo Venturini , Raffaele Colasanto , Andrea Necchi , Ugo De Giorgi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 558)

DOI

10.1200/JCO.2024.42.4_suppl.558

Abstract #

558

Poster Bd #

E7

Abstract Disclosures

Similar Posters

First Author: Lorenzo Antonuzzo

First Author: Yizhen Lai

First Author: Helen H. Moon

First Author: Inkeun Park